补肾健脾方对HBeAg阳性乙肝病毒携带者的免疫调节作用  被引量:8

Immunomodulatory effect of the Bushen Jianpi recipe on HBeAg-positive hepatitis B virus carriers

在线阅读下载全文

作  者:陈英杰[1] 周大桥[1] 童光东[1] 贺劲松[1] 邢宇锋[1] 

机构地区:[1]广州中医药大学深圳附属医院,广东深圳518033

出  处:《中医临床研究》2013年第12期1-5,共5页Clinical Journal Of Chinese Medicine

基  金:科技部"十一.五""艾滋病和病毒性肝炎等重大传染病防治"重大专项(2008ZX10005-008):慢性乙肝病毒携带者的证候规律及中医药治疗方案研究;负责人:周大桥

摘  要:目的:评价补肾健脾方对HBeAg阳性乙肝病毒携带者血清细胞因子的调节作用。方法:采用多中心、随机、双盲、对照的研究方法。400例HBeAg阳性乙肝病毒携带者随机分为治疗组和对照组,分别给予补肾健脾方、安慰剂治疗52周。观察治疗前后血清细胞因子IL-2、IL-4、IL-10、IFN-γ、TNF-α水平及HBVDNA载量的变化。结果:治疗52周后,补肾健脾方组患者的血清细胞因子IL-2和IFN-γ显著上升,TNF-α、IL-4和IL-10则明显下降(P<0.01);治疗前后的各细胞因子差值比较,均优于安慰剂对照组(P<0.01);而血清HBVDNA载量较基线下降>1log10,>2log10,>3log10比例均显著高于安慰剂对照组(P<0.01)。结论:补肾健脾方通过调节Th1/Th2型细胞因子水平,打破HBV感染的免疫耐受状态,实现对HBV复制的抑制作用。Objective: To estimate the modulatory effect ofBushen Jianpi recipe on serum cytokines in HBeAg-positive hepatitis B virus carriers. Methods: With the multi-center, randomized, double-blinded and controlled methods, 400 cases of were randomly assigned to treated group and control group. During the 52-week treatments, Bushen Jianpi recipe was applied in treated group and placebo was adopted in control group. The serum cytokine levels, including IL-2, IL-4, IL-10, IFN-γ, and TNF-α, and HBV DNA level were detected pre-treatment and post-treatment in all patients. Results: After the 52-week treatments, in the Bushen Jianpi recipe treated group, the serum levels of IL-2 and IFN-γ were markedly increased, while the serum levels of TNF-a, IL-4 and IL-10 were obviously decreased (P〈0.01). The variation of each cytokine level pre-treatment and post-treatment in the Bushen Jianpi recipe treated group was significantly different from that in the placebo control group (P〈0.01). The proportions of patients in the Bushen Jianpi recipe treated group in whom serum HBV DNA levels decreased from the baseline by more than 1 log10, 2 lOgl0, 3 log10 were significantly higher than those in the placebo control group(P〈0.01). Conclusion: Bushen Jianpi recipe breaks the immunological tolerance of hepatitis B virus infection by modulating the level of Thl/Th2 type cytokines, to achieve the inhibition for HBV replication.

关 键 词:乙型肝炎病毒携带者 免疫因子 中医药疗法 补肾健脾方 随机对照试验 

分 类 号:R512.61[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象